In summary, tumor-derived TNC dominates the effect on myeloid cell polarization and tumor growth in the in vivo and cellular models of breast cancer that we have used in this study, as well as controls CCL2 transcription in tumor cells. The gene discussed is CCL2; the disease is breast carcinoma.